By A.I. and Staff Reporters
SPONSOR: http://www.CertifiedMedicalPlanner.org
***
***
Trump says pharma tariffs could be as high as 250%
The president revealed that he plans to formally announce tariffs on the pharmaceutical industry “within the next week or so” in an attempt to force drug manufacturing to the US, he told CNBC several days ago.
PBMs: https://medicalexecutivepost.com/2019/01/18/on-pbms-pharmacy-benefits-management/
It would start with a “small” tariff, Trump said, before rising to 150% in a year to a year and a half, and eventually to 250%.
Pharma companies have argued that tariffs could drive up costs and threaten their ability to fund research for new medicines.
COMMENTS APPRECIATED
Like and Subscribe
***
***
Filed under: "Ask-an-Advisor", Ask a Doctor, CMP Program, Drugs and Pharma, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, iMBA, Inc., mental health | Tagged: AI, artificial intelligence, Big Pharma, certified medical planner, ChatGPT, CNBC, Donald Trump, drug prices, DRUG TARIFFS, Drugs, healthcare costs, medical costs, medicine, Morning Brew, openAI, PBMs, pharmaceutical industry, tariffs, Technology | Leave a comment »














